Trial Information

Summary: Anemia-Chronic Kidney Disease

Medford Women's Clinic is currently recruiting subjects to participate in an experimental study for treating anemia related to chronic kidney disease.

Study drug and procedures will be made available to you at no cost. This is a 17 week trial of an IV medication vs. oral iron to treat your anemia . All patients will receive either the IV medication or oral iron for their anemia, there is placebo on this study.

Inclusion Criteria:

  • 12 years of age or older
  • Chronic Kidney Disease
  • Current Anemia
  • Not on Dialysis Therapy

You will NOT qualify if you:

  • Are anticipating or scheduled to have a kidney transplant
  • Are pregnant or breast-feeding
  • Have received a blood transfusion within the last 8 weeks
  • Are allergic to ferrous sulfate
  • Have Hepatitis B or C or are HIV positive

For more information,

Contact:

Dorothy Bray, CCRC
Medford Women's Clinic
3170 State Street
Medford, OR 97504
Telephone: 541-864-8928
Fax: 541-245-3317
Email:

Profile Page: Medford Women's Clinic, Medford, OR

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:54 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA